Ovarian suppression in combination endocrine adjuvant therapy in premenopausal women with early breast cancer
详细信息 查看全文
- 作者：Rowan T. Chlebowski ; Kathy Pan ; Nananda F. Col
- 关键词：Breast cancer ; Ovarian suppression ; Aromatase inhibitor ; Tamoxifen ; Premenopausal ; Gonadotropin ; releasing hormone agonists
- 刊名：Breast Cancer Research and Treatment
- 出版年：2017
- 出版时间：January 2017
- 年：2017
- 卷：161
- 期：2
- 页码：185-190
- 全文大小：
- 刊物类别：Medicine
- 刊物主题：Oncology;
- 出版者：Springer US
- ISSN：1573-7217
- 卷排序：161
文摘
PurposeThe benefits of adding ovarian suppression to either tamoxifen or aromatase inhibitors as adjuvant breast cancer therapy in premenopausal women are controversial. Therefore, we performed a systematic literature review and meta-analysis of relevant randomized trials.